Prostate specific antigen: an updated review.

Détails

ID Serval
serval:BIB_F9552818E390
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Titre
Prostate specific antigen: an updated review.
Périodique
Canadian Journal of Urology
Auteur(s)
So A., Goldenberg L., Gleave M.E.
ISSN
1195-9479
Statut éditorial
Publié
Date de publication
12/2003
Volume
10
Numéro
6
Pages
2040-2050
Langue
anglais
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Résumé
Since its discovery in 1979, serum PSA has revolutionized how physicians manage men with prostate cancer. PSA screening, although currently under much debate, has been recommended by most North American medical bodies, including the Canadian Urological Association, to be performed as a shared-decision making process after discussing with patients the pros and cons of treatment. Although most commonly thought of as a screening tool, serum PSA has also been used to predict tumor volume, stage and prognosis in patients before and after treatment. In this review, we examine PSA testing and its effectiveness in the diagnosis and management of prostate cancer. Further, we also evaluate recent literature regarding the use of PSA derivatives and other prostate cancer markers, such as proPSA, bPSA, and hk2
Mots-clé
Humans, Male, Neoplasm Staging, Predictive Value of Tests, Prostate-Specific Antigen/blood, Prostatic Neoplasms/blood, Prostatic Neoplasms/diagnosis, Time Factors, Tissue Kallikreins/blood
Pubmed
Création de la notice
25/01/2008 9:39
Dernière modification de la notice
03/03/2018 22:53
Données d'usage